Skip to main content

Table 1 Genotype and allele frequencies of rs4685 (SF3B1), rs12366395 (TBX3), rs72758040 (MAP3K1), rs8853 (TBX3), and rs1061651 (TBX3) in BRCA1/2-negative breast cancer cases and controls

From: Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population

  

All BC cases (n = 486)

Families with ≥ 2 BC and/or OC cases (n = 308)

Families with a single case, diagnosis at ≤ 50 years of age (n = 178)

Genotype or allele

Controls (%) (n = 1258)

BC cases (%)

OR [95% CI]

p-valuea

BC cases (%)

OR [95% CI]

p-valuea

BC cases (%)

OR [95% CI]

p-valuea

rs4685 (SF3B1)

 C/C

504 (40.1)

213 (43.8)

(ref.)

133 (43.2)

(ref.)

80 (44.9)

(ref.)

 C/T

560 (44.5)

213 (43.8)

0.9 [0.7–1.1]

0.35

139 (45.1)

0.9 [0.7–1.2]

0.68

74 (41.6)

0.8 [0.5–1.1]

0.30

 T/T

194 (15.4)

60 (12.4)

0.7 [0.5–1.0]

0.07

36 (11.7)

0.7 [0.4–1.0]

0.09

24 (13.5)

0.7 [0.4–1.2]

0.34

 C/T + T/T

754 (59.9)

273 (56.2)

0.8 [0.6–1.0]

0.15

175 (56.8)

0.8 [0.6–1.1]

0.33

98 (55.1)

0.8 [0.5–1.1]

0.22

 Allele C

1568 (62.3)

639 (65.7)

(ref.)

405 (65.7)

(ref.)

234 (65.7)

(ref.)

 Allele T

948 (37.7)

333 (34.3)

0.8 [0.7–1.0]

0.06

211 (34.3)

0.8 [0.7–1.0]

0.12

122 (34.3)

0.8 [0.6–1.0]

0.23

rs12366395 (TBX3)

 A/A

989 (78.6)

355 (73.0)

(ref.)

220 (71.4)

(ref.)

135 (75.8)

(ref.)

 A/G

252 (20.0)

124 (25.5)

1.3 [1.0–1.7]

0.01

82 (26.6)

1.4 [1.0–1.9]

0.01

42 (23.6)

1.2 [0.8–1.7]

0.3

 G/G

17 (1.4)

7 (1.4)

1.1 [0.4–2.7]

0.8

6 (1.9)

1.5 [0.6–4.0]

0.4

1 (0.6)

0.4 [0.05–3.2]

0.7

 A/G + G/G

269 (21.4)

131 (27.0)

1.3 [1.0–1.7]

0.01

88 (28.6)

1.4 [1.1–1.9]

0.008

43 (24.2)

1.1 [0.8–1.6]

0.4

 Allele A

2230 (88.6)

834 (85.8)

(ref.)

522 (84.7)

(ref.)

312 (87.6)

(ref.)

 Allele G

286(11.4)

138 (14.2)

1.2 [1.0–1.6]

0.02

94 (15.3)

1.4 [1.0–1.8]

0.009

44 (12.4)

1.1 [0.7–1.5]

0.6

rs72758040 (MAP3K1)

 G/G

866 (68.8)

317 (65.4)

(ref.)

194 (63.3)

(ref.)

123 (69.1)

(ref.)

 G/C

307 (24.4)

119 (24.5)

1.0 [0.8–1.3]

0.65

76 (24.7)

1.1 [0.8–1.4]

0.54

43 (24.2)

0.9 [0.6–1.4]

1.0

 C/C

85 (6.8)

50 (10.1)

1.6 [1.1–2.3]

0.01

38 (12.0)

1.9 [1.3–3.0]

0.001

12 (6.7)

0.9 [0.5–1.8]

1.0

 G/C + C/C

392 (31.2)

168 (34.6)

1.1 [0.9–1.4]

0.16

113 (36.7)

1.2 [0.9–1.6]

0.06

55 (30.9)

0.9 [0.7–1.3]

1.0

 Allele G

2039 (81.0)

755 (77.7)

(ref.)

466 (75.6)

(ref.)

-

289 (81.2)

(ref.)

 Allele C

477 (19.0)

217 (22.3)

1.2 [1.0–1.4]

0.02

150 (24.4)

1.3 [1.1–1.6]

0.003

67 (18.8)

0.9 [0.7–1.3]

0.9

rs8853 (TBX3)

 T/T

512 (40.7)

195 (40.1)

(ref.)

125 (40.6)

(ref.)

70 (39.3)

(ref.)

 T/C

563 (44.8)

217 (44.7)

1.0 [0.8–1.2]

0.95

132 (42.9)

0.9 [0.7–1.2]

0.78

85 (47.8)

1.1 [0.7–1.5]

0.60

 C/C

183 (14.5)

74 (15.2)

1.0 [0.7–1.4]

0.74

51 (16.5)

1.1 [0.7–1.6]

0.50

23 (12.9)

0.9 [0.5–1.5]

0.80

 T/C + C/C

746 (59.3)

291 (59.9)

1.0 [0.8–1.2]

0.87

183 (59.4)

1.0 [0.7–1.2]

1.00

108 (60.7)

1.0 [0.7–1.4]

0.74

 Allele T

1587 (63.1)

607 (62.4)

(ref.)

382 (62.0)

(ref.)

225 (63.2)

(ref.)

 Allele C

929 (36.9)

365 (37.6)

1.0 [0.8–1.1]

0.76

234 (38.0)

1.0 [0.8–1.2]

0.65

131 (36.8)

0.9 [0.7–1.2]

0.99

rs1061651 (TBX3)

 T/T

414 (32.9)

154 (31.7)

(ref.)

98 (31.8)

(ref.)

-

56 (31.5)

(ref.)

 T/C

596 (47.4)

240 (49.4)

1.0 [0.8–1.3]

0.54

153 (49.7)

1.0 [0.8–1.4]

0.61

87 (48.9)

1.0 [0.7–1.5]

0.71

 C/C

248 (19.7)

92 (18.9)

0.9 [0.7–1.3]

1.00

57 (18.5)

0.9 [0.6–1.3]

0.92

35 (19.7)

1.0 [0.6–1.6]

0.90

 T/C + C/C

844 (67.1)

332 (68.3)

1.0 [0.8–1.3]

0.64

210 (68.2)

1.0 [0.8–1.3]

0.73

122 (68.5)

1.0 [0.7–1.4]

0.73

 Allele T

1424 (56.6)

548 (56.4)

(ref.)

349 (56.7)

(ref.)

199 (55.9)

(ref.)

 Allele C

1092 (43.4)

424 (43.6)

1.0 [0.8–1.1]

0.93

267 (43.3)

0.9 [0.8–1.1]

0.98

157 (44.1)

1.0 [0.8–1.2]

0.84

  1. BC breast cancer, OC ovarian cancer, OR odds ratio, CI confidence interval, Ref reference
  2. aFisher’s exact test; bold values are statistically significant (p < 0.05)